Role in Immune Pathology
The spectrum of immunological disorders is broad and divided into several groups based on mechanisms of development and clinical presentation. There are four main categories:
- Immunodeficiencies — conditions characterized by insufficient protective functions.
- Allergic diseases and hypersensitivity — excessive, exaggerated reactions to antigens.
- Autoimmune diseases — pathological aggression of the system against the body's own tissues.
- Diseases with immune-mediated inflammation.
Thus, immunodeficiency represents a malfunction where the immune system fails to perform its primary function due to the absence or dysfunction of specific defensive elements.
Etiology and Basic Classification
Globally, all immunodeficiencies are divided into two broad groups, with the key difference lying in their mechanisms of origin. Understanding this distinction is critical for differential diagnosis.
Primary immunodeficiencies (PIDs) have a strictly genetic origin. Their development is triggered by gene mutations that lead to defective protein products. As a result, the immune response cascade is blocked or functions improperly.
Secondary (acquired) immunodeficiencies arise in the postnatal period against the background of initially normal genetics. Their development is provoked by external factors:
- Infectious agents (herpesviruses and HIV are especially dangerous).
- Iatrogenic factors (e.g., targeted immunosuppressive therapy in the treatment of other diseases).
- Physical factors (radiation exposure).
- Chemical agents (various toxins and poisons).
Clinical Presentation of Genetic Defects
Patients with primary immunodeficiencies have a specific clinical profile centered around a pronounced infection syndrome. Infections in these patients are extremely severe, frequently recurrent, and resistant to standard conservative therapy.
Typical manifestations include sepsis, otitis media, pneumonia, and meningitis. Additionally, comorbid conditions often manifest due to reduced immune surveillance, including malignancies, various allergic reactions, and autoimmune disorders.
History of Study and Management
Active study of primary immunodeficiencies began in the early 1950s. The first described condition was X-linked agammaglobulinemia (a disease associated with a mutation on the X chromosome). To date, scientists have identified over 100 different gene mutations responsible for encoding immune response proteins. The classification of these conditions is based on the affected component of the immune system and clinical-genetic features.
When PID is suspected, the diagnostic algorithm necessarily includes a detailed family history to identify a genetic trail among blood relatives. The combination of a positive family history and recurrent infections is a direct indication for a detailed evaluation of the patient's immune status. Therapeutic management in such cases involves prolonged courses of antibiotic therapy using the latest generation of drugs to control the infectious process.